Analyst firms · H.C. Wainwright · IMUX

H.C. Wainwright IMUX price target and rating history

Immunic Inc. (IMUX) · Health Care

H.C. Wainwright rates Immunic Inc. (IMUX) Buy with a $10 price target, as of its latest action on Nov 25, 2024. It has published 3 rating actions on IMUX since September 2021, including 0 upgrades and 0 downgrades. Across 3 firms with a IMUX price target in the last 12 months, the median target is $7.

Current rating
Buy
Price target
$10
Median target, all firms
$7
Actions on IMUX
3

H.C. Wainwright price target on IMUX

$26$18$1020222023202420252026
H.C. Wainwright price target on IMUX, each point a stated target, September 2021 to November 2024.

Every H.C. Wainwright rating on IMUX

How other firms rate IMUX

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Cantor FitzgeraldOverweightOct 23, 2026
WedbushOutperform$45Aug 17, 2026
Wolfe ResearchOutperformMay 22, 2026
StifelBuy$2.50Apr 17, 2026
D. Boral CapitalHoldApr 15, 2026
GuggenheimBuy$7Mar 24, 2026

Questions about H.C. Wainwright and IMUX

What is H.C. Wainwright's price target for IMUX?
H.C. Wainwright's latest stated price target for Immunic Inc. (IMUX) is $10, from its action on Nov 25, 2024.
What is H.C. Wainwright's rating on IMUX?
H.C. Wainwright rates IMUX Buy, a bullish rating, as of Nov 25, 2024.
When did H.C. Wainwright last change its view on IMUX?
On Nov 25, 2024, H.C. Wainwright starts coverage at Buy, price target $10.
How does H.C. Wainwright's IMUX target compare with other analysts?
Across 3 firms with a IMUX price target in the last 12 months, the median target is $7.

All H.C. Wainwright ratingsIMUX news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.